by Jessica Casebolt | Jun 21, 2024 | Opioid/Substance Use Disorders, Tea Leaves
In the realm of health care, addiction remains highly stigmatized, particularly among pregnant women who use drugs, facing condemnation across various systems. Agencies often remove newborns from drug-positive mothers without providing adequate support, contributing...
by Jessica Casebolt | Jun 21, 2024 | Public Health/Prevention, Tea Leaves
The United States Surgeon General proposed the implementation of warning labels on social media platforms to caution parents about potential risks to adolescents’ mental health. Similar to labels on tobacco and alcohol products, these warnings aim to inform...
by Jessica Casebolt | Jun 21, 2024 | Providers, Tea Leaves
A recent study from the University of Pennsylvania highlighted that COVID-19 patients admitted to hospitals with fewer nursing resources had significantly lower survival rates. Analyzing nearly 88,000 Medicare patients discharged from 237 hospitals between April and...
by Jessica Casebolt | Jun 21, 2024 | Opioid/Substance Use Disorders, Tea Leaves
In 2019, the U.S. federal government initiated the HEALing Communities Study to tackle rising opioid overdose rates by implementing evidence-based interventions such as distributing naloxone and expanding access to addiction medications. However, data published in the...
by Jessica Casebolt | Jun 21, 2024 | Life Sciences, Tea Leaves
The U.S. Patent and Trademark Office has introduced a new rule aimed at curbing the misuse of patent thickets in the pharmaceutical industry. These patent thickets, made up of numerous patents with incremental changes to drugs, are exploited by companies to prolong...
Recent Comments